Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,200
Closed -$396K 4974
2021
Q3
$396K Buy
+3,200
New +$412K ﹤0.01% 3450
2020
Q2
Sell
-5,000
Closed -$326K 3606
2020
Q1
$326K Buy
5,000
+2,000
+67% +$158K ﹤0.01% 2236
2019
Q4
$236K Sell
3,000
-500
-14% -$38.9K ﹤0.01% 3337
2019
Q3
$279K Buy
+3,500
New +$275K ﹤0.01% 3007
2019
Q2
Sell
-4,000
Closed -$316K 3720
2019
Q1
$316K Buy
+4,000
New +$292K ﹤0.01% 2565
2018
Q4
Sell
-6,500
Closed -$519K 3609
2018
Q3
$519K Buy
+6,500
New +$485K ﹤0.01% 2425
2018
Q1
Sell
-3,600
Closed -$246K 3570
2017
Q4
$246K Buy
+3,600
New +$239K ﹤0.01% 2824

Other funds holding XYL

John Overdeck's XYL Position: Q2 2026 in Review

John Overdeck increased its Xylem (XYL) stake by 53% in Q2 2026, buying an estimated $8.69M and bringing the position to 216,869 shares worth $25.6M. The position accounts for 0.02% of the portfolio, ranked #905.

John Overdeck first reported a position in XYL in Q2 2013 and has held it in 31 quarters since. The position peaked at $134M in Q2 2023. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • John Overdeck held 216,869 shares of Xylem worth $25.6M as of Q2 2026.
  • John Overdeck bought 75,318 Xylem shares in Q2 2026, an estimated $8.69M.
  • Xylem made up 0.02% of John Overdeck's portfolio in Q2 2026, its #905 holding.
  • John Overdeck first reported a position in Xylem in Q2 2013 and has held it in 31 quarters since.
  • John Overdeck's Xylem position peaked at $134M in Q2 2023.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.